Wille Finance
VC Fund
Zürich, Switzerland
Wille Finance is an international, Swiss-based multi-family office, focusing on private equity, real estate, digital media and listed assets.Within Private Equity we carry out both Early Stage (focus Life Science & ICT) and Late Stage investments. Whilst in Real Estate we maintain a long-term, value-add approach to our strategy with a focuson main European cities. Our Digital Media focus is on companies interweaving media, content and technology. The Listed Assets strategy is to maintain a net-long portfolio.
- Total investments:
- 40
- Last investment:
- Lead investor:
- 13%
Last updated:
For AI agents: llms.txt
Industries Wille Finance invests in
Stages Wille Finance invests in
Countries Wille Finance invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $396k–$4.6M
- Series A
- $5.9M–$36M
- Series B
- $9.8M–$85M
Investment Focus
Industry
- Health Care 10 (25%)
- Biotechnology 10 (25%)
- Software 9 (23%)
- Information Technology 7 (18%)
- SaaS 5 (13%)
Stage
- Series A 9 (23%)
- Seed 6 (15%)
- Series B 6 (15%)
- Series C 5 (13%)
- Venture - Series Unknown 5 (13%)
Country
- France 9 (23%)
- Germany 8 (20%)
- Switzerland 7 (18%)
- United States 2 (5%)
- Italy 1 (3%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Albert Iten
CEO
|
CEO | Total investments: 0 | Find email | |
Katharina Iten
Investor , Venture Capital & Private Equity Investments
|
Investor , Venture Capital & Private Equity Investments | Total investments: 1 | Find email | |
Reto Hertler
Executive
|
Executive | Total investments: 1 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Healthcare professionals are now overwhelmed by the volume of patients and images. They need new tools. As safeguards of our Healthcare system, they need to be empowered and to participate in the AI production process. This is our mission through our co-creation projects. | $16M / Venture - Series Unknown / Sep 22, 2026 | ||
| Tenpoint Therapeutics is a biotechnology company pursuing vision-restoring engineered cell-based therapeutics. | $85M / Series B / Jan 28, 2026 | ||
| Edflex offers content for businesses such as articles, videos, podcasts, online courses, and books. It is a SaaS solution that connects companies to access online corporate training content. Edflex is working to improve everyone's training by making it more understandable. The company's goal is to be the innovator in bringing togetherparticipants in online training by developing an easy-to-follow learning route. The teams at Edflex strive every day to locate and offer instructional content in a way that makes learning seem natural and effortless, rather than like an extra effort. | $18M / Oct 01, 2025 | ||
| Newronika restores brain and body functions with innovative technologies. We translate our deep knowledge on biosignal decoding into clinical practice, with the aim of improving treatments, health, and wellness. With our revolutionary brain devices, the patient receives the right stimulation at the right moment, thus becoming able to perform normaldaily activities and improve quality of life. Newronika is the spin-off company of two leading research institutions in Italy, the Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Hospital and the University of Milan. Newronika comprises a multidisciplinary team formed from Neuroscience research groups and involves scientists with expertise in neurophysiology, neurology, biomedical engineering, neuropsychology, bioinformatics, and biotechnologies. | $14.2M / Series B / Feb 13, 2025 | ||
| Happydemics is the story of frustration become conviction. A frustration with the complexity of market research, neglected by decision-makers in favor of a simplistic and stereotypical vision of a target. But Happydemics is above all the conviction that they must reinvent the experience of studies for brands, but also for respondents, bydemocratizing access to the opinion of all people. Happydemics was born, and 5 years later, Their conviction is stronger every day! | $13.7M / Series B / Dec 03, 2024 | ||
| mediaire GmbH is a software for computer-based diagnosis in radiology was developed, which is locally installed | $12.7M / Nov 13, 2024 | ||
| Wegrow is an AI software company that offers AI agents for business solutions. It uses AI to identify best practices for marketing, sales, IT, Finance, HR, and Supply Chain departments and turn them into business results. | $7.8M / Series A / Sep 18, 2024 | ||
| Sirfull Technology offers innovative software solutions dedicated to industrial assets management.The company specializes in developing welding quality and equipment life cycle management cloud software and offers software to manage welding quality control and technical documentation as well as an equipment inspection software that collaborates theinspection, monitoring, and risk management of industrial equipment to centralize in a collaborative platform, enabling its clients to optimize their business processes through digital manufacturing services. | $6.6M / Venture - Series Unknown / Sep 02, 2024 | ||
| SamanTree Medical is a swiss innovative medical device company providing a breakthrough imaging solution with the potential to improve patient care and cancer surgery outcome. Based on confocal microscopy, SamanTree Medical’s solution brings accurate and full margin control by the surgeon, in the operating room. | $14M / Series B / Jul 16, 2024 | ||
| StoryBox provides a Software as a Service solution for businesses to create, share and structure video content to make it searchable. With the system, companies can create and organize smartphone-based videos for any application scenario. Using the app, videos can be created and shared by every employee using templates. The app suggests picturesettings and scene lengths automatically and offers an automated creation which includes corporate design. The content can be stored in the DSGVO-compliant StoryBox cloud and can be accessed, filtered and analyzed from anywhere. Customers include Iveco, Erste Group, Evonik, Alten, and KTM. | $5.9M / Series A / Jun 19, 2024 | ||
| See all 40 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does Wille Finance invest in?
Wille Finance invests primarily in Health Care, Biotechnology and Software startups, most often at Series A and Seed stage. Most of the 40 investments tracked by Shizune back companies in France. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Wille Finance's check size?
Wille Finance typically joins rounds of $396k–$4.6M at Seed, $5.9M–$36M at Series A and $9.8M–$85M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Wille Finance participates in.
How do I contact Wille Finance?
Public channels for Wille Finance include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Wille Finance?
The team at Wille Finance includes Albert Iten (CEO), Katharina Iten (Investor , Venture Capital & Private Equity Investments) and Reto Hertler (Executive). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
